Showing results (1-10 of 5,157) with videos related to

Sort By:
Pageof 516
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and DiseaseSylvain Broussy
Journal of Combinatorial Chemistry|October 16, 2007
Solid phase synthesis of highly substituted tetrahydropyrans by tandem ene-reaction/intramolecular Sakurai cyclizationSylvain Broussy, Herbert Waldmann
Journal of Enzyme Inhibition and Medicinal Chemistry|May 6, 2020
Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)Sylvain Broussy, Hanna Laaroussi, Michel Vidal
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 6, 2022
Structural and ITC Characterization of Peptide-Protein Binding: Thermodynamic Consequences of Cyclization Constraints, a Case Study on Vascular Endothelial Growth Factor LigandsJean-François Gaucher, Marie Reille-Seroussi, Sylvain Broussy
International Journal of Biological Macromolecules|March 27, 2026
Computational insights into conformational dynamics and allosteric regulation in protein arginine methyltransferase 4 (PRMT4)Amr Abbas, Zhanpeng Miao, Jia Jin, et al.
Molecules (Basel, Switzerland)|November 27, 2021
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed PeptidomimeticsXiaoqing Ye, Jean-François Gaucher, Michel Vidal, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2003
1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosisSylvain Broussy, Yannick Coppel, Michel Nguyen, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosisMichel Nguyen, Annaïk Quémard, Sylvain Broussy, et al.
Pageof 516